Safety and efficacy of ustekinumab in adult patients with moderately to severely active Crohns disease: A retrospective observational study
Latest Information Update: 17 Jul 2018
At a glance
- Drugs Ustekinumab (Primary) ; Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Adverse reactions; Therapeutic Use
- 17 Jul 2018 New trial record
- 05 Jun 2018 Results presented at the Digestive Disease Week 2018